US medical device maker Teleflex is carving up its business in a series of deals totalling $2bn with private equity firms acquiring the Irish operations.
Aerska raised $21m recently for its RNA therapies tackling diseases like Alzheimer's. Co-founders Jack O’Meara and David Hardwicke talk to The Currency about what’s next.
The start-up, often described as an "Uber for pathology", has just secured a crucial approval to carry out pathological testing in the UK. CEO Donal O'Shea speaks about building out its UK footprint and plans to scale up in the US.
The company was founded by Oxford researchers and run from Ireland. Attempts to reshore it through an examinership have fallen apart, while a separate UK court case looms large.
Gareth Sheridan’s company saw an uptick in revenue over a six-month period but it is still generating high losses and contending with a lawsuit from an investment bank.
The company was once valued near €100m but was bought out of examinership for €6.9m. Co-founder Kieran Daly and Rob George of new owner Hamilton Beach explain what’s next.
A court has approved a scheme to pay restitution of $318m to victims of fraudster Greg Lindberg with funds coming from the sale of the Clanwilliam Group to a private equity firm. Clanwillian had no link to the fraud but it was holding up the deal.
The Irish private-equity backed company has informed US authorities that it was targeted by a hacking incident with more than 240,000 people believed to be affected.
The multinational has struck a deal to sell its Galway design and manufacturing hub to Quasar Medical. Its Roscommon site is untouched by the deal.
The National Standards Authority of Ireland was suspended from certifying in-vitro diagnostic devices for three months, all the while the agency faces an “overhaul” by the Government.
© 2026 Currency Media Limited
